Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 21;13(5):161.
doi: 10.3390/diseases13050161.

Effects of Sex and Race on Epidemiology and Comorbidities of Patients with Irritable Bowel Syndrome: A Rome III Era Retrospective Study

Affiliations

Effects of Sex and Race on Epidemiology and Comorbidities of Patients with Irritable Bowel Syndrome: A Rome III Era Retrospective Study

Jacqueline Liu et al. Diseases. .

Abstract

Background: Irritable bowel syndrome (IBS) is a prevalent disorder of gut-brain interaction (DGBI) with a negative impact on quality of life and healthcare expenditure. This study aimed to investigate sex-based differences in a large cohort of IBS patients from a multiracial safety-net hospital.

Methods: An electronic query was performed using the International Classification of Diseases, 9th Revision (ICD-9) coding to identify 740 outpatients with IBS between 1 January 2005 and 30 September 2007. Demographic data and ICD-9 coded comorbidities were extracted from electronic records. Data analysis used descriptive statistics and multiple logistic regression analyses.

Results: Comorbid anxiety and depression were significantly more prevalent in female patients (A:24%, p = 0.03; D:29%, p = 0.008) compared with male patients. White female IBS patients had a higher risk for anxiety but not depression compared with non-White patients (p = 0.02). Female sex (p = 0.02), obesity (p = 0.007), and age above fifty (p = 0.02) but not race/ethnicity were significant risk factors for depression. IBS with constipation was more prevalent in female patients (p = 0.005) and in Hispanic compared with non-Hispanic patients (p = 0.03).

Conclusions: Significant sex-based and racial/ethnic differences were identified related to body mass index (BMI), age, and IBS subtypes in this study. Comorbid mood disorders occurred significantly more frequently in female patients, and risk factors for comorbid depression included female sex, older age, and obesity but not race/ethnicity.

Keywords: anxiety; comorbidities; depression; eating disorders; irritable bowel syndrome; racial differences; sex.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Forest plots for factors associated with depression and anxiety by multiple logistic regression analysis. Forest plots presenting odds ratios (ORs) and 95% confidence intervals (CIs) for demographic, socioeconomic, and clinical factors associated with depression (Panel A, top) and anxiety (Panel B, bottom). An OR > 1 indicates higher odds relative to the reference group. BMI is body mass index; Underweight: BMI < 18.5; Normal: BMI between 18.5 and 24.9; Overweight: BMI between 25 and 29.9; Obese: BMI ≥ 30. Unspecified employment also includes students. OR ratio bars are depicted in black for significant values.
Figure 2
Figure 2
Forest plot for factors associated with IBS with constipation by multiple logistic regression analysis. A forest plot showing ORs and 95% CIs for demographic, socioeconomic, and clinical predictors of IBS with constipation compared with non-constipation IBS subtypes. An OR > 1 reflects higher odds of constipation-predominant IBS relative to the reference group. Non-Hispanic race/ethnicity includes White, Black, and Asian. BMI is body mass index; Underweight: BMI < 18.5; Normal: BMI between 18.5 and 24.9; Overweight: BMI between 25 and 29.9; Obese: BMI ≥ 30. Unspecified employment also includes students. OR ratio bars are depicted in black for significant values.

Similar articles

References

    1. Black C.J., Ford A.C. Global burden of irritable bowel syndrome: Trends, predictions and risk factors. Nat. Rev. Gastroenterol. Hepatol. 2020;17:473–486. doi: 10.1038/s41575-020-0286-8. - DOI - PubMed
    1. Chey W.D., Kurlander J., Eswaran S. Irritable bowel syndrome: A clinical review. JAMA. 2015;313:949–958. doi: 10.1001/jama.2015.0954. - DOI - PubMed
    1. Lacy B.E., Patel N.K. Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome. J. Clin. Med. 2017;6:99. doi: 10.3390/jcm6110099. - DOI - PMC - PubMed
    1. Ford A.C., Sperber A.D., Corsetti M., Camilleri M. Irritable bowel syndrome. Lancet. 2020;396:1675–1688. doi: 10.1016/S0140-6736(20)31548-8. - DOI - PubMed
    1. Canavan C., West J., Card T. The epidemiology of irritable bowel syndrome. Clin. Epidemiol. 2014;6:71–80. doi: 10.2147/clep.S40245. - DOI - PMC - PubMed

LinkOut - more resources